Insider · CIK 0001347383
David E Cohen
Files at EVMN (Evommune, Inc.). First filing Jun 3, 2026, latest Jun 3, 2026.
David E Cohen files SEC Form 4 as director at EVMN (Evommune, Inc.). Since Jun 3, 2026, David E Cohen has reported 0 open-market buys worth $0 and 1 open-market sell worth $123k, the latest filed on Jun 3, 2026.
A track record needs three past buys with six months of prices behind them; David E Cohen has 0, so none is measured yet.
The newest scored trade: sold $123k of EVMN on Jun 2, 2026, filed Jun 3, 2026, scored 30 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $123k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EVMN: Evommune, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Evommune, Inc. | $123k 6,056 shares | -26% | +32% from low-37% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | EVMN Evommune, Inc. | SOpen-market sale Common Stock10b5-1 | -5,456 | $20.21 | $110k | 18,209 | Jun 3, 2026 |
| Jun 2, 2026 | EVMN Evommune, Inc. | SOpen-market sale Common Stock10b5-1 | -600 | $21.38 | $13k | 17,609 | Jun 3, 2026 |
| Jun 2, 2026 | EVMN Evommune, Inc. | AGrant or award Stock Option (Right to buy)derivative10b5-1 | +15,673 | $0.00 | $0 | 15,673 | Jun 3, 2026 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Common Stock | +6,056 | - | - | 23,665 | Nov 12, 2025 |
| Nov 7, 2025 | EVMN Evommune, Inc. | CConversion Series Seed Preferred Stockderivative | -51,588 | - | - | 0 | Nov 12, 2025 |
| Nov 5, 2025 | EVMN Evommune, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +37,960 | $0.00 | $0 | 37,960 | Nov 7, 2025 |
Questions about David E Cohen
Answered from the filings on this page, as of the latest one.
Is David E Cohen buying or selling?
In the last 12 months David E Cohen reported 0 open-market buys worth $0 and 1 open-market sell worth $123k on SEC Form 4; the latest was sold $123k of EVMN on Jun 2, 2026. Grants, option exercises and tax withholding are not counted.
How did David E Cohen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David E Cohen has 0.
Where does David E Cohen file Form 4?
David E Cohen has filed Form 4 at EVMN (Evommune, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.